Kenneth Kovan Insider Profile

4 Followers
Kenneth Kovan, Senior Officer at BioVaxys Technology, holds 7.35M shares in BioVaxys Technology (Ticker: BVAXF).
tipranks
Kenneth  Kovan

Kenneth Kovan
BioVaxys Technology (BVAXF)
Senior Officer

Not Ranked
Kenneth Kovan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$368K
100.00%
A breakdown of Kenneth Kovan's holdings

Insider Roles

BioVaxys Technology
(BVAXF)
Senior Officer
Roles that Kenneth Kovan holds in companies

Most Profitable Insider Trade

Stock:
BioVaxys Technology
(BVAXF)
Rating:Informative Buy
Date:Jul 22, 2021 - Jul 22, 2022
Return:-38.80%
The most profitable trade made by Kenneth Kovan

Kenneth Kovan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioVaxys Technology
Feb 01, 2024
Senior Officer
Uninformative Buy
19.00K
$367.64K
Success Rate for
BVAXF
0 out of 1 profitable transactions on
BVAXF
0%
Average Return for
BVAXF
Average return per transaction on
BVAXF
-38.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 22, 2021
Informative Buy
C$6.25K
-
C$0.22
-38.80%
Aug 04, 2022
Uninformative Buy
C$40.33K
-
C$0.10
Jul 15, 2023
Informative Buy
C$5.17K
-
C$0.02
Feb 01, 2024
Uninformative Buy
C$19.00K
-
C$0.03
List of latest transactions for each holding click on a transaction to see Kenneth Kovan's performance on stock

Kenneth Kovan insider profile FAQ

What is the percentage of profitable transactions made by Kenneth Kovan?
The percentage of profitable transactions made by Kenneth Kovan is ―.
    What is the average return per transaction made by Kenneth Kovan?
    The average return per transaction made by Kenneth Kovan is ―.
      What stocks does Kenneth Kovan hold?
      Kenneth Kovan holds: BVAXF stocks.
        What was Kenneth Kovan’s latest transaction?
        Kenneth Kovan latest transaction was an Uninformative Buy of $19.00K.
          What was Kenneth Kovan's most profitable transaction?
          Kenneth Kovan’s most profitable transaction was an Informative Buy of BVAXF stock on July 22, 2021. The return on the trade was -38.80%.
            What is Kenneth Kovan's role in BioVaxys Technology?
            Kenneth Kovan's role in BioVaxys Technology is Senior Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.